In view of the importance of IL-33 in contributing to the pathogenesis of CRC, herein, we review the critical role of IL-33 in the pathogenesis of CRC development and evaluate its potential as biomarker for assessing tumor aggressiveness and disease prognosis. The gene discussed is IL33; the disease is colorectal carcinoma.